p53 Tumor suppresser gene expression in the mouse ovary during an artificially induced ovulatory cycle

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 2, 1999, Pages 107-114

  Yaron, Yuval ^a   Schwartz, Dov ^b   Evans, Mark I ^c   Aloni, Ronit ^b   Kapon, Ahuva ^b   Rotter, Varda ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c HUTZEL HOSPITAL   (United States)

Author keywords

Ovary; Ovulation induction; Protein p53

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CHORIONIC GONADOTROPIN; PROTEIN P53; RNA; SERIC GONADOTROPIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORPUS LUTEUM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRANULOSA CELL; LUTEAL CELL; NONHUMAN; NORTHERN BLOTTING; OVARY; OVULATION INDUCTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MOUSE; OVULATION;

ANIMALS; CELL DIFFERENTIATION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; FEMALE; GENE EXPRESSION; GENES, P53; GRANULOSA CELLS; MICE; MICE, TRANSGENIC; OVARY; OVULATION; OVULATION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033017533     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lane DP: p53, Guardian of the genome. Nature 1992;358: 15-16
2. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 1991;351:453-456
3. Warnakulasuriya KA, Johnson NW: Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992;21: 404-408
4. Cho KR, Vogelstein B: Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J Cell Biochem (suppl) 1992;16G:137-141
5. Johnson BE, Kelley MJ: Overview of genetic and molecular events in the pathogenesis of lung cancer. Chest (suppl 1) 1993;103:1s-3s
6. Cline MJ, Jat PS, Foti A: Molecular mechanisms in the evolution of chronic myelocytic leukemia. Leuk Lymphoma 1992;7:283-287
7. Prokocimer M, Rotter V: Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineages. Blood 1994;84:2391-2411
8. Raycroft L, Wu H, Lozano G: Transcriptional activation by wild-type but not transforming mutants of the p53 antioncogene. Science 1990;249:1049-1051
9. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence-specific DNA-binding protein. Science 1991;252:1708-1711
10. Shaw P, Bovey R, Tardy S, Rahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;89:4495-4499
11. Almon E, Goldfinger N, Kapon A, Schwartz D, Levine AJ, Rotter V: Testicular tissue specific expression of the p53 suppressor gene. Dev Biol 1993;156:107-116
12. Schwartz D, Glodfinger N, Rotter V: Expression of p53 protein in spermatogenesis is confined to the tetraploid pachyrene primary spermatocytes. Oncogene 1993;8: 1487-1494
13. Ronen D, Rotter V, Reisman D: Expression from murine p53 promoter is mediated by factor binding to a downstream Helix-Loop-Helix recognition motif. Proc Natl Acad Sci USA 1991;88:4128-4132
14. German CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell Biol 1982;2:1044-1051
15. Eliyahu D, Michalovitz D, Eliyahu S, et al: Wild-type p53 can inhibit oncogene mediated focus formation. Proc Natl Acad Sci USA 1989;86:8763-8767
16. Mercer WE, Shields MT, Amin M, et al: Negative growth regulation in glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990;87:6166-6170
17. Shaulsky G, Goldfinger N, Peled A, et al: Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 1991;88:8982-8986
18. Yonish-Rouach E, Resnitzky D, Lotem J, et al: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991;352:345-347
19. Murdoch WJ: Programmed cell death in preovulatory ovine follicles. Biol Reprod 1995;53:8-12
20. Hurwitz A, Ruutiainen-Altman K, Marzella L, et al: Follicular atresia as an apoptotic process: Atresia-associated increase in the ovarian expression of the putative apoptotic marker sulfated glycoprotein-2. J Soc Gynecol Invest 1996; 3:199-208
21. Chun SY, Eisenhauer KM, Minami S, et al: Hormonal regulation of apoptosis in early antral follicles: Follicle-stimulating hormone as a major survival factor. Endocrinology 1996;137:1447-1456
22. Tilly KI, Banerjee S, Banerjee PP, et al: Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: Gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 1995;136:1394-1402
23. Hsueh AJ, Eisenhauer K, Chun SY, et al: Gonadal cell apoptosis. Recent Prog Horm Res 1996;51:433-456
24. Tilly JL, Tilly KI, Kenton ML, et al: Expression of members of the bcl-2 gene family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology 1995;136:232-241
25. Amsterdam A, Keren-Tal I, Aharoni D: Cross-talk between cAMP and p53-generated signals in induction of differentiation and apoptosis in steroidogenic granulosa cells. Steroids 1996;61:252-256
26. Keren-Tal I, Suh BS, Dantes A, et al: Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp Cell Res 1995;218:283-295
27. Hakuno N, Koji T, Yano T, et al: Fas/APO-1 /CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology 1996;137:1938-1948
28. Zheng J, Fricke PM, Reynolds LP, et al: Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 1994;51:623-632
29. Fraser HM, Lunn SF, Cowen GM, et al: Induced luteal regression in the primate: Evidence for apoptosis and changes in c-myc protein. J Endocrinol 1995;147:131-137
30. Schmid P, Lorenz A, Hameister H, et al: Expression of p53 during mouse embryogenesis. Development 1991;113: 857-865
31. Soddu S, Blandino G, Scardigli R, et al: Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol 1996;134:193-204
32. Halevy O: p53 Gene is up-regulated during skeletal muscle cell differentiation. Biochem Biophys Res Commun 1993;192: 714-719
33. Rotter V, Schwartz D, Almon E, et al: Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc Natl Acad Sci USA 1993;90:9075-9079
34. Stouffer RL: Corpus luteum function and dysfunction. Clin Obstet Gynecol 1990;33:668-689
35. Whittemore AS, Harris R, Intyre J: Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case control studies. Am J Epidemiol 1992;136:1184-1203
36. Rossing MA, Daling JR, Weiss NS, et al: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-776
37. Willemsen W, Kruitwagen R, Bastiaans B, et al: Ovarian stimulation and granulosa cell tumor. Lancet 1993;341: 986-988